Maroufi Shahnam Sedigh, Kiaei Mehrdad Mesbah, Sangi Siavash, Aligholizadeh Maryam, Abbasi Mohsen, Moradimajd Parisa, Rajabzadeh Rezvan, Saei Azam
Department of Anesthesia, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
Department of Anesthesiology and Pain Medicine, Hasheminejad Kidney Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
J Res Pharm Pract. 2025 Mar 11;13(3):92-99. doi: 10.4103/jrpp.jrpp_4_25. eCollection 2024 Jul-Sep.
Shivering is one of the most common complications due to disturbances in the thermoregulatory system after regional anesthesia, leading to adverse outcomes and decreased patient satisfaction. Ketamine and tramadol are considered mild analgesics that affect the thermoregulatory center. This triple-blind, randomized clinical trial aims to explore the comparative efficacy of intravenous ketamine and tramadol in reducing postspinal anesthesia shivering in high-risk urological surgeries.
A total of 90 patients undergoing urological surgeries under spinal anesthesia at Shahid Hasheminejad Hospital in Tehran in 2024 were randomized into three groups: ketamine (0.5 mg/kg), tramadol (0.5 mg/kg), and placebo (normal saline). Variables, including ambient temperature, patient demographics, surgery duration, and anesthetic techniques, were meticulously controlled. The primary outcome was the incidence of shivering, measured using the Crossley and Mahajan scale. Data were analyzed using the SPSS software Version 19, employing Chi-square tests, analysis of variance, and logistic regression.
The patients were homogeneous regarding demographic and surgical variables. No significant difference was found in patients' body temperature upon admission. The incidence of shivering was significantly lower in the tramadol group (23.3%) compared to the ketamine group (36.7%) and placebo group (60%) ( = 0.013). Tramadol demonstrated superior efficacy with minimal side effects. Logistic regression analysis confirmed that patients in the tramadol group were significantly less likely to experience shivering (odds ratio = 0.286; 95% confidence interval: 0.098-0.834, = 0.022). Ketamine, while effective, had a higher incidence of hemodynamic fluctuations and psychotropic effects.
The incidence of shivering was significantly lower in the tramadol group compared to the ketamine and placebo groups. Tramadol demonstrated superior efficacy with minimal side effects. While effective, ketamine had a higher incidence of hemodynamic fluctuations and psychotropic effects.
寒战是区域麻醉后体温调节系统紊乱最常见的并发症之一,会导致不良后果并降低患者满意度。氯胺酮和曲马多被认为是影响体温调节中枢的轻度镇痛药。这项三盲随机临床试验旨在探讨静脉注射氯胺酮和曲马多在高危泌尿外科手术中减少脊髓麻醉后寒战的比较疗效。
2024年,在德黑兰的哈希米内贾德烈士医院,共有90例接受脊髓麻醉的泌尿外科手术患者被随机分为三组:氯胺酮组(0.5mg/kg)、曲马多组(0.5mg/kg)和安慰剂组(生理盐水)。包括环境温度、患者人口统计学特征、手术持续时间和麻醉技术等变量均得到严格控制。主要结局是使用克罗斯利和马哈拉詹量表测量的寒战发生率。使用SPSS软件19版进行数据分析,采用卡方检验、方差分析和逻辑回归。
患者在人口统计学和手术变量方面具有同质性。入院时患者体温无显著差异。曲马多组的寒战发生率(23.3%)显著低于氯胺酮组(36.7%)和安慰剂组(60%)(P = 0.013)。曲马多显示出卓越的疗效且副作用最小。逻辑回归分析证实,曲马多组患者发生寒战的可能性显著更低(比值比 = 0.286;95%置信区间:0.098 - 0.834,P = 0.022)。氯胺酮虽然有效,但血流动力学波动和精神效应的发生率更高。
与氯胺酮组和安慰剂组相比,曲马多组的寒战发生率显著更低。曲马多显示出卓越的疗效且副作用最小。氯胺酮虽然有效,但血流动力学波动和精神效应的发生率更高。